CORC

在结果中检索

CORC

浏览/检索结果: 共11条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Design and synthesis of selenazole-substituted ritonavir analogs 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 卷号: 28, 期号: 14, 页码: 2379-2381
作者:  Liu, Jun;  Zhao, Chuanfang;  Qiao, Junfei;  Du, Yuguo
收藏  |  浏览/下载：24/0  |  提交时间：2019/06/20
CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats 期刊论文
ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 8, 页码: 1386-1392
作者:  Xu, Ye;  Zhang, Yi-fan;  Chen, Xiao-yan;  Zhong, Da-fang
收藏  |  浏览/下载：25/0  |  提交时间：2019/01/08
硒唑合成的新方法研究及其应用 学位论文
北京: 中国科学院生态环境研究中心, 2018
作者:  乔俊飞
收藏  |  浏览/下载：140/0  |  提交时间：2019/07/16
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 期刊论文
HEPATOLOGY, 2018, 卷号: 68
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Efficacy and safety of paritaprevir/ritonavir/ombitasvir combined with dasabuvir in non-cirrhotic Asian adult patients with newly diagnosed and treated chronic HCV genotype 1b infection: a randomized, double-blind, placebo-controlled study - China data]. 期刊论文
Chinese journal of hepatology, 2018, 卷号: 26, 页码: 359-364
作者:  Wei L;  Cheng J;  Luo J;  Li Z P;  Duan J L
收藏  |  浏览/下载：13/0  |  提交时间：2019/11/19
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir combined with ribavirin in Asian adult patients with chronic HCV genotype 1b infection and compensated cirrhosis]. 期刊论文
Chinese journal of hepatology, 2018, 卷号: 26, 页码: 353-358
作者:  Wei L;  Wang G Q;  Sarah J;  Cheng Q;  Xie M R
收藏  |  浏览/下载：8/0  |  提交时间：2019/11/19
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/11/19
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 期刊论文
HEPATOLOGY, 2018, 卷号: Vol.68, 页码: 584A
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：4/0  |  提交时间：2019/02/25
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace